Ionis Pharmaceuticals, Inc. (IONS)

79.14 +0.51 (+0.65%) USD  |  NASDAQ  |  Dec 11, 16:00
79.00 -0.14 (-0.18%) Pre-Market: 08:06
More

Ionis Pharmaceuticals Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for IONS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Cogent Biosciences, Inc. --